Indole-6-Carboxylic Acid CAS 1670-82-2 Purity > 98.0% (HPLC) Lub Hoobkas Zoo

Lus piav qhia luv luv:

Lub npe tshuaj: Indole-6-Carboxylic Acid

CAS: 1670-82-2 Nr

Purity:> 98.0% (HPLC)

Cov tsos mob: Yellowish hmoov

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com


Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Chaw tsim tshuaj paus Supply nrog High Quality, Commercial Production
Lub npe tshuaj: Indole-6-Carboxylic Acid CAS: 1670-82-2

Chemical Properties:

Tshuaj npe Indole-6-Carboxylic Acid
Synonyms 6-Indole Carboxylic Acid;6-Carboxyndole;1H-Indole-6-Carboxylic Acid
CAS Nr 1670-82-2 : kuv
CAT Number Qauv TSIS MUAJ: RF-PI1478
Tshuag xwm txheej Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons
Molecular Formula C9H7 NPO 2
Molecular Luj 161.16 Nws
Hom Ruifu Tshuaj

Specifications:

Yam khoom Specifications
Qhov tshwm sim Yellowish hmoov
Purity / Analysis Method > 98.0% (HPLC)
Purity > 98.0% (Neutralization Titration)
Melting Point 251.0 ~ 255.0 ℃
Poob rau ziab ≤0.50%
Residue ntawm Ignition ≤0.50%
Tag nrho cov impurities <2.00%
Heavy Metals (raws li Pb) <20 ppm
Test Standard Enterprise Standard
Kev siv Pharmaceutical Intermediates

Pob & Cia:

Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj.

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo.

Qhov zoo:

1

FAQ:

Daim ntawv thov:

Indole-6-Carboxylic Acid (CAS: 1670-82-2) yog siv los ua cov organic synthesis intermediates, tshuaj intermediates.Reactant rau kev npaj ntawm D-glutamic acid-based inhibitors ntawm E. coli MurD ligase;Reactant rau kev npaj ntawm indolylindazoles thiab indolylpyrazolopyridines li interleukin-2 inducible T cell kinase inhibitors;Reactant rau kev npaj ntawm amide conjugates nrog ketoprofen, raws li inhibitors ntawm Gli1-mediated transcription nyob rau hauv Hedgehog txoj kev;Reactant rau kev npaj ntawm piperazine-bisamide analogs li tib neeg txoj kev loj hlob hormone secretagogue receptor antagonists rau kev kho mob rog;Reactant rau kev npaj ntawm pyridinyl carboxylates ntawm esterification nrog chlorohydroxypyridine li SARS-CoV 3CL proinhibitors;Reactant rau kev npaj ntawm (indolecarbonyl)-D-phenylglycinamide amides ua yam Xa inhibitors.

Sau koj cov lus ntawm no thiab xa tuaj rau peb